Quantum Biopharma Ltd. Files June 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Jun 10, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, regulatory-filing
TL;DR
Quantum Biopharma filed its June 6-K, confirming 20-F reporting.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on June 10, 2025, reporting for the month of June 2025. The company, incorporated in A6 and headquartered in Toronto, Canada, operates in the Pharmaceutical Preparations sector. This filing indicates they are submitting their report under Form 20-F.
Why It Matters
This filing serves as an update for investors and regulatory bodies regarding Quantum Biopharma's ongoing reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Numbers
- 001-39152 — Commission File Number (Identifies the company's SEC filing history)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the report
- FSD Pharma Inc. (company) — Former name of the filer
- June 10, 2025 (date) — Filing date
- 20250610 (date) — Conformed period of report
- 001-39152 (other) — Commission File Number
- Form 20-F (document) — Annual report form
- Form 6-K (document) — Report type
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
What was Quantum Biopharma Ltd.'s former name?
Quantum Biopharma Ltd.'s former name was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
The company's principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Under which annual report form does the registrant file?
The registrant indicates it files annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The SIC code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 10, 2025 regarding Quantum Biopharma Ltd. (QNTM).